This episode explains the central chemical engine of inflammation.
Most everyday drugs patients recognize β ibuprofen, aspirin, steroids, montelukast β all work somewhere on this single pathway.
If Episode 1 was the map, this is the highway everything travels on.
π Download Slides (PDF)
Download Slides
All inflammation begins with cell membrane phospholipids.
Damage or immune activation triggers:
β Phospholipase Aβ
This releases:
β Arachidonic Acid
No arachidonic acid = no inflammatory mediators
Drug that blocks this step:
This is why steroids feel dramatically stronger than NSAIDs.
Once arachidonic acid exists, it must choose a direction:
| Pathway | Enzyme | Products | What They Do |
|---|---|---|---|
| COX Pathway | Cyclooxygenase | Prostaglandins & Thromboxane | Pain, fever, swelling |
| LOX Pathway | Lipoxygenase | Leukotrienes | Bronchoconstriction, mucus, asthma |
Every common anti-inflammatory drug targets one of these branches.
Produces Prostaglandins (PGEβ, PGIβ) and Thromboxane (TXAβ)
Clinical effects:
Blocked by:
Patients experience:
But NOT immune suppression.
Produces Leukotrienes (LTBβ, LTCβ, LTDβ, LTEβ)
Clinical effects:
Blocked by:
Important insight:
Asthma is not a prostaglandin disease β it is primarily a leukotriene disease.
Steroids block:
β Phospholipase Aβ (upstream of BOTH pathways)
So they reduce:
NSAIDs turn off one faucet Steroids shut off the water main
| Drug Class | What Improves | What Does NOT Improve |
|---|---|---|
| Antihistamines | Itch & allergy | Pain & arthritis |
| NSAIDs | Pain & fever | Asthma control |
| Leukotriene blockers | Asthma | Arthritis pain |
| Steroids | Almost everything | Long-term safety |
Understanding failures becomes predictable.
You cannot treat leukotriene disease with prostaglandin drugs β and you cannot treat immune disease with symptom drugs.